Skip to main content

Head and Neck Cancer: A Review of the Impact of Treatment Delay on Outcome

Advances in Therapy volume 35, pages 153–160 (2018)Cite this article

Abstract

Delay between the initial symptoms, diagnosis, and the definitive treatment of head and neck cancers is associated with tumor progression and upstaging. These delays may lead to poor outcomes and may mandate more aggressive treatments with unnecessary morbidity and even mortality. The multidisciplinary team approach for the treatment of patients with head and neck cancers has improved organization of standard clinical guidelines, but this development has yet to translate into a demonstrable impact on survival. We review the association between waiting times (time between diagnosis and initiation of treatment) and clinical outcomes in patients with head and neck squamous cell carcinoma (HNSCC).

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price includes VAT (USA)
Tax calculation will be finalised during checkout.

References

  1. Chaturvedi AK, Anderson WF, Lortet-Tieulent J, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol. 2013;31:4550–9.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Gupta B, Johnson NW, Kumar N. Global epidemiology of head and neck cancers: a continuing challenge. Oncology. 2016;91:13–23.

    Article  PubMed  Google Scholar 

  3. Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008–2030): a population-based study. Lancet Oncol. 2012;13:790–801.

    Article  PubMed  Google Scholar 

  4. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:359–86.

    Article  Google Scholar 

  5. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46:765–81.

    CAS  Article  PubMed  Google Scholar 

  6. Gatta G, Botta L, Sanchez MJ, et al. Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: the EUROCARE-5 population-based study. Eur J Cancer. 2015;51:2130–43.

    Article  PubMed  Google Scholar 

  7. Neal RD. Do diagnostic delays in cancer matter? Br J Cancer. 2009;101:9–12.

    Article  Google Scholar 

  8. Brouha X, Tromp D, Hordijk GJ, Winnubst J, De Leeuw R. Role of alcohol and smoking in diagnostic delay of head and neck cancer patients. Acta Otolaryngol. 2005;125:552–6.

    Article  PubMed  Google Scholar 

  9. Lund VJ, Howard DJ, Wei WI. Tumors of the nose, sinuses and nasopharynx. Stuttgart: Thieme; 2014. p. 596.

    Google Scholar 

  10. Tufano RP, Mokadam NA, Montone KT, et al. Malignant tumors of the nose and paranasal sinuses: hospital of the University of Pennsylvania Experience 1990–1997. Am J Rhinol. 1999;13:117–23.

    CAS  Article  PubMed  Google Scholar 

  11. Bilimoria KY, Ko CY, Tomlinson JS, et al. Wait times for cancer surgery in the United States: trends and predictors of delays. Ann Surg. 2011;253:779–85.

    Article  PubMed  Google Scholar 

  12. Chen Z, King W, Pearcey R, Kerba M, Mackillop WJ. The relationship between waiting time for radiotherapy and clinical outcomes: a systematic review of the literature. Radiother Oncol. 2008;87:3–16.

    Article  PubMed  Google Scholar 

  13. Jensen AR, Nellemann HM, Overgaard J. Tumor progression in waiting time for radiotherapy in head and neck cancer. Radiother Oncol. 2007;84:5–10.

    Article  PubMed  Google Scholar 

  14. Waaijer A, Terhaard CH, Dehnad H, et al. Waiting times for radiotherapy: consequences of volume increase for the TCP in oropharyngeal carcinoma. Radiother Oncol. 2003;66:271–6.

    Article  PubMed  Google Scholar 

  15. Wyatt RM, Beddoe AH, Dale RG. The effects of delays in radiotherapy treatment on tumour control. Phys Med Biol. 2003;48:139–55.

    CAS  Article  PubMed  Google Scholar 

  16. Mackillop WJ, Bates JH, O‘Sullivan B, Withers HR. The effect of delay in treatment on local control by radiotherapy. Int J Radiat Oncol Biol Phys. 1996;34:243–50.

    CAS  Article  PubMed  Google Scholar 

  17. van Bockel LW, Verduijn GM, Monninkhof EM, Pameijer FA, Terhaard CH. The importance of actual tumor growth rate on disease free survival and overall survival in laryngeal squamous cell carcinoma. Radiother Oncol. 2014;112:119–24.

    Article  PubMed  Google Scholar 

  18. Fortin A, Bairati I, Albert M, Moore L, Allard J, Couture C. Effect of treatment delay on outcome of patients with early-stage head-and-neck carcinoma receiving radical radiotherapy. Int J Radiat Oncol Biol Phys. 2002;52:929–36.

    Article  PubMed  Google Scholar 

  19. Kowalski LP, Carvalho AL. Influence of delay and clinical upstaging in the prognosis of head and neck cancer. Oral Oncol. 2001;37:94–8.

    CAS  Article  PubMed  Google Scholar 

  20. van Harten MC, de Ridder M, Hamming-Vrieze O, Smeele LE, Balm AJ, van den Brekel MW. The association of treatment delay and prognosis in head and neck squamous cell carcinoma (HNSCC) patients in a Dutch comprehensive cancer center. Oral Oncol. 2014;50:282–90.

    Article  PubMed  Google Scholar 

  21. van Harten MC, Hoebers FJ, Kross KW, van Werkhoven ED, van den Brekel MW, van Dijk BA. Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival. Oral Oncol. 2015;51:272–8.

    Article  PubMed  Google Scholar 

  22. Caudell JJ, Locher JL, Bonner JA. Diagnosis-to-treatment interval and control of locoregionally advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 2011;137:282–5.

    Article  PubMed  Google Scholar 

  23. Murphy CT, Galloway TJ, Handorf EA, et al. Survival impact of increasing time to treatment initiation for patients with head and neck cancer in the United States. J Clin Oncol. 2016;34:169–78.

    CAS  Article  PubMed  Google Scholar 

  24. Huang J, Barbera L, Brouwers M, Browman G, Mackillop WJ. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol. 2003;21:555–63.

    Article  PubMed  Google Scholar 

  25. Patel UA, Brennan TE. Disparities in head and neck cancer: assessing delay in treatment initiation. Laryngoscope. 2012;122:1756–60.

    Article  PubMed  Google Scholar 

  26. Rogers SN, Pabla R, McSorley A, Lowe D, Brown JS, Vaughan ED. An assessment of deprivation as a factor in the delays in presentation, diagnosis and treatment in patients with oral and oropharyngeal squamous cell carcinoma. Oral Oncol. 2007;43:648–55.

    CAS  Article  PubMed  Google Scholar 

  27. Guizard AV, Dejardin O, Launay L, et al. What are the real waiting times for therapeutic management of head and neck cancer: a study in the general population in the north–west of France. Eur Arch Otorhinolaryngol. 2016;273:3951–8.

    Article  PubMed  Google Scholar 

  28. Primdahl H, Nielsen AL, Larsen S, et al. Changes from 1992 to 2002 in the pretreatment delay for patients with squamous cell carcinoma of larynx or pharynx: a Danish nationwide survey from DAHANCA. Acta Oncol. 2015;45:156–61.

    Article  Google Scholar 

  29. Lyhne NM, Christensen A, Alanin MC, et al. Waiting times for diagnosis and treatment of head and neck cancer in Denmark in 2010 compared to 1992 and 2002. Eur J Cancer. 2013;49:1627–33.

    CAS  Article  PubMed  Google Scholar 

  30. Patil RD, Meinzen-Derr JK, Hendricks BL, Patil YJ. Improving access and timeliness of care for veterans with head and neck squamous cell carcinoma: a multidisciplinary team’s approach. Laryngoscope. 2016;126:627–31.

    Article  PubMed  Google Scholar 

  31. Friedland PL, Bozic B, Dewar J, Kuan R, Meyer C, Phillips M. Impact of multidisciplinary team management in head and neck cancer patients. Br J Cancer. 2011;104:1246–8.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  32. Birchall M, Bailey D, King P. Effect of process standards on survival of patients with head and neck cancer in the south and west of England. Br J Cancer. 2004;91:1477–81.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  33. Kelly SL, Jackson JE, Hickey BE, Szallasi FG, Bond CA. Multidisciplinary clinic care improves adherence to best practice in head and neck cancer. Am J Otolaryngol. 2013;34:57–60.

    Article  PubMed  Google Scholar 

  34. Starmer H, Sanguineti G, Marur S, Gourin CG. Multidisciplinary head and neck cancer clinic and adherence with speech pathology. Laryngoscope. 2011;121:2131–5.

    Article  PubMed  Google Scholar 

  35. Toustrup K, Lambertsen K, Birke-Sørensen H, Ulhøi B, Sørensen L, Grau C. Reduction in waiting time for diagnosis and treatment of head and neck cancer—a fast track study. Acta Oncol. 2011;50:636–41.

    Article  PubMed  Google Scholar 

  36. Ouwens MM, Hermens RR, Hulscher MM, et al. Impact of an integrated care program for patients with head and neck cancer on the quality of care. Head Neck. 2009;31:902–10.

    Article  PubMed  Google Scholar 

  37. Klausen OG, Olofsson J, Rosengren B. A long waiting time for radiotherapy: not acceptable for patients with neoplasms. Tidsskr Nor Laegeforen. 1989;109:2324–5.

    CAS  PubMed  Google Scholar 

  38. León X, de Vega M, Orús C, Morán J, Vergés J, Quer M. The effect of waiting time on local control and survival in head and neck carcinoma patients treated with radiotherapy. Radiother Oncol. 2003;66:277–81.

    Article  PubMed  Google Scholar 

  39. Barton MB, Morgan G, Smee R, Tiver KW, Hamilton C, Gebski V. Does waiting time affect the outcome of larynx cancer treated by radiotherapy? Radiother Oncol. 1997;44:137–41.

    CAS  Article  PubMed  Google Scholar 

  40. Lee AW, Chan DK, Fowler JF, et al. T1 nasopharyngeal carcinoma: the effect of waiting time on tumor control. Int J Radiat Oncol Biol Phys. 1994;30:1111–7.

    CAS  Article  PubMed  Google Scholar 

Download references

Acknowledgements

This article was written by members of the International Head and Neck Scientific Group (http://www.IHNSG.com).

Funding

No funding or sponsorship was received for this study or publication of this article.

Authorship

All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.

Disclosures

Andrés Coca-Pelaz, Robert P. Takes, Kate Hutcheson, Nabil F. Saba, Missak Haigentz Jr., Carol R. Bradford, Remco de Bree, Primož Strojan, Valerie J. Lund, William M. Mendenhall, Iain J. Nixon, Miquel Quer, Alessandra Rinaldo, and Alfio Ferlito have nothing to declare.

Compliance with Ethics Guidelines

This article is based on previously conducted and reported studies and does contain studies with human participants performed by some of the authors, but does not contain any studies with animals performed by any of the authors. These previously reported studies are clearly referenced.

Data Availability

Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.

Author information

Authors and Affiliations

  1. Department of Otolaryngology, Hospital Universitario Central de Asturias, Oviedo, Spain

    Andrés Coca-Pelaz

  2. Department of Otolaryngology-Head and Neck Surgery, Radboud University Medical Center, Nijmegen, The Netherlands

    Robert P. Takes

  3. Department of Head and Neck Surgery, Section of Speech Pathology and Audiology, MD Anderson Cancer Center, Houston, TX, USA

    Kate Hutcheson

  4. Department of Hematology and Medical Oncology, The Winship Cancer Institute of Emory University, Atlanta, GA, USA

    Nabil F. Saba

  5. Division of Hematology/Oncology, Department of Medicine, Morristown Medical Center/Atlantic Health System, Morristown, NJ, USA

    Missak Haigentz Jr.

  6. Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, MI, USA

    Carol R. Bradford

  7. Department of Head and Neck Surgical Oncology, UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands

    Remco de Bree

  8. Department of Radiation Oncology, Institute of Oncology, Ljubljana, Slovenia

    Primož Strojan

  9. Professorial Unit, Ear Institute, University College London, London, UK

    Valerie J. Lund

  10. Department of Radiation Oncology, University of Florida, Gainesville, FL, USA

    William M. Mendenhall

  11. Department of Surgery and Otolaryngology, Head and Neck Surgery, Edinburgh University, Edinburgh, UK

    Iain J. Nixon

  12. Department of Otolaryngology, Hospital Santa Creu i Sant Pau, Barcelona, Spain

    Miquel Quer

  13. University of Udine School of Medicine, Udine, Italy

    Alessandra Rinaldo

  14. Coordinator of the International Head and Neck Scientific Group, Padua, Italy

    Alfio Ferlito

Authors
  1. Andrés Coca-Pelaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert P. Takes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kate Hutcheson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nabil F. Saba
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Missak Haigentz Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Carol R. Bradford
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Remco de Bree
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Primož Strojan
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Valerie J. Lund
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. William M. Mendenhall
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Iain J. Nixon
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Miquel Quer
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Alessandra Rinaldo
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Alfio Ferlito
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrés Coca-Pelaz.

Additional information

Enhanced content

To view enhanced content for this article go to http://www.medengine.com/Redeem/DF3B4F605BD6EDA9.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Coca-Pelaz, A., Takes, R.P., Hutcheson, K. et al. Head and Neck Cancer: A Review of the Impact of Treatment Delay on Outcome. Adv Ther 35, 153–160 (2018). https://doi.org/10.1007/s12325-018-0663-7

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12325-018-0663-7

Keywords

  • Head and neck cancer
  • Oncology
  • Prognosis
  • Survival
  • Treatment
  • Waiting time